TARO - Taro Pharmaceutical GAAP EPS of $0.40 beats by $0.09 revenue of $164.94M beats by $8.88M May, 20 2024 05:25 PM Taro Pharmaceutical Industries Ltd. 2024-05-20 17:25:49 ET More on Taro Pharmaceutical Estée Lauder, Reckitt, Taro Pharma fall amid cancer risk in acne treatments Seeking Alpha’s Quant Rating on Taro Pharmaceutical Historical earnings data for Taro Pharmaceutical Financial information for Taro Pharmaceutical For further details see: Taro Pharmaceutical GAAP EPS of $0.40 beats by $0.09, revenue of $164.94M beats by $8.88M